title: Sluder's sphenopalatine ganglion neuralgia--treatment with 88% phenol.
abstract: Patients who experience chronic recurring head and face pain present a diagnostic and therapeutic challenge. Treatment options for Sluder's neuralgia, an uncommon cause for recurring head and face pain, are controversial. We reviewed the outcomes of patients who underwent intranasal phenolization of the sphenopalatine ganglion for the treatment of Sluder's neuralgia. Eight patients were treated with intranasal cauterization of the sphenopalatine ganglion between 1990 and 1995. Patients were treated an average of 13 times. Overall, patients experienced a 90% decrease in head and face pain for an average of 9.5 months duration. Interestingly, the patients described recurrent pain as less severe, less frequent, and of shorter duration. Intranasal phenolization of the sphenopalatine ganglion appears to be a safe and effective, although temporary, treatment for patients with Sluder's neuralgia. This article will review the symptomatology, differential diagnosis, and phenolization technique for treatment of Sluder's neuralgia.
authors.affiliation: Department of Otorhinolaryngology, Mayo Clinic, Rochester, Minnesota 55905, USA.
authors.forename: C M
authors.initials: CM
authors.lastname: Puig
authors.forename: C L
authors.initials: CL
authors.lastname: Driscoll
authors.forename: E B
authors.initials: EB
authors.lastname: Kern
mesh_terms: D005156:Facial Neuralgia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005726:Ganglia, Parasympathetic; D006261:Headache / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008499:Medical Records; D009994:Osmolar Concentration; D010159:Palate / Q000294:innervation*; D019800:Phenol / Q000008:administration & dosage / Q000627:therapeutic use*; D012189:Retrospective Studies; D013101:Sphenoid Sinus / Q000294:innervation*
chemical_list: D019800:Phenol